ETLI.DE vs. XMLH.DE
ETLI.DE (L&G Pharma Breakthrough UCITS ETF) and XMLH.DE (L&G Healthcare Technology & Innovation UCITS ETF USD Acc) are both Health & Biotech Equities funds - ETLI.DE tracks the Solactive Pharma Breakthrough Value while XMLH.DE tracks the ROBO Global Healthcare Technology and Innovation Index. Both are passively managed. Over the past 5 years, ETLI.DE returned 3.45%/yr vs -2.64%/yr for XMLH.DE. A 0.68 correlation means they provide meaningful diversification when combined. Both charge a 0.49% expense ratio.
Performance
ETLI.DE vs. XMLH.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ETLI.DE achieves a 10.27% return, which is significantly higher than XMLH.DE's 8.59% return.
ETLI.DE
- 1D
- -0.31%
- 1M
- 7.24%
- 6M
- 10.75%
- YTD
- 10.27%
- 1Y
- 33.89%
- 3Y*
- 9.54%
- 5Y*
- 3.45%
- 10Y*
- —
XMLH.DE
- 1D
- -1.84%
- 1M
- 8.59%
- 6M
- 2.66%
- YTD
- 8.59%
- 1Y
- 38.31%
- 3Y*
- 7.34%
- 5Y*
- -2.64%
- 10Y*
- —
ETLI.DE vs. XMLH.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
ETLI.DE L&G Pharma Breakthrough UCITS ETF | 10.27% | 22.18% | 0.42% | -12.66% | -2.85% | 4.96% | 15.32% | 7.92% |
XMLH.DE L&G Healthcare Technology & Innovation UCITS ETF USD Acc | 8.59% | 11.69% | 8.01% | -4.50% | -29.19% | 7.76% | 49.95% | -0.52% |
Correlation
The correlation between ETLI.DE and XMLH.DE is 0.59, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.59 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.62 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.66 |
Correlation (All Time) Calculated using the full available price history since Jun 26, 2019 | 0.68 |
The correlation between ETLI.DE and XMLH.DE has been stable across timeframes, ranging from 0.59 to 0.68 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ETLI.DE vs. XMLH.DE — Risk / Return Rank
ETLI.DE
XMLH.DE
ETLI.DE vs. XMLH.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for L&G Pharma Breakthrough UCITS ETF (ETLI.DE) and L&G Healthcare Technology & Innovation UCITS ETF USD Acc (XMLH.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ETLI.DE | XMLH.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.08 | ||
| Sortino ratioReturn per unit of downside risk | -0.20 | ||
| Omega ratioGain probability vs. loss probability | 1.29 | 1.31 | -0.02 |
| Calmar ratioReturn relative to maximum drawdown | 3.73 | 2.47 | +1.27 |
| Martin ratioReturn relative to average drawdown | 10.84 | 5.53 | +5.31 |
Loading charts...
Drawdowns
ETLI.DE vs. XMLH.DE - Drawdown Comparison
The maximum ETLI.DE drawdown since its inception was -30.84%, smaller than the maximum XMLH.DE drawdown of -51.48%. Use the drawdown chart below to compare losses from any high point for ETLI.DE and XMLH.DE.
Loading charts...
Drawdown Indicators
| ETLI.DE | XMLH.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -30.84% | -51.48% | +20.64% |
Max Drawdown (1Y)Largest decline over 1 year | -9.04% | -15.46% | +6.42% |
Max Drawdown (3Y)Largest decline over 3 years | -23.14% | -28.40% | +5.26% |
Max Drawdown (5Y)Largest decline over 5 years | -30.84% | -50.58% | +19.74% |
Current DrawdownCurrent decline from peak | -5.71% | -21.11% | +15.40% |
Average DrawdownAverage peak-to-trough decline | -9.97% | -25.17% | +15.20% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.11% | 6.91% | -3.80% |
Volatility
ETLI.DE vs. XMLH.DE - Volatility Comparison
The current volatility for L&G Pharma Breakthrough UCITS ETF (ETLI.DE) is 5.68%, while L&G Healthcare Technology & Innovation UCITS ETF USD Acc (XMLH.DE) has a volatility of 7.32%. This indicates that ETLI.DE experiences smaller price fluctuations and is considered to be less risky than XMLH.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ETLI.DE | XMLH.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.68% | 7.32% | -1.64% |
Volatility (6M)Calculated over the trailing 6-month period | 14.11% | 15.92% | -1.81% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.45% | 21.00% | -1.55% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 17.41% | 22.54% | -5.13% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.71% | 23.80% | -5.09% |
ETLI.DE vs. XMLH.DE - Expense Ratio Comparison
Both ETLI.DE and XMLH.DE have an expense ratio of 0.49%.
Dividends
ETLI.DE vs. XMLH.DE - Dividend Comparison
Neither ETLI.DE nor XMLH.DE has paid dividends to shareholders.
Frequently Asked Questions
ETLI.DE and XMLH.DE have a correlation of 0.59, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Both ETFs have the same 0.49% expense ratio. The better choice depends on whether you care most about return, fees, risk, or income.
ETLI.DE and XMLH.DE have the same expense ratio: 0.49% per year.
ETLI.DE tracks Solactive Pharma Breakthrough Value, while XMLH.DE tracks ROBO Global Healthcare Technology and Innovation Index. They also come from different issuers: Legal & General and L&G.
Find the right allocation for ETLI.DE and XMLH.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer